Erythropoietin and Chronic Kidney Disease Alter Hepatic Expression of Cytochrome P450 Enzymes and Drug Transport Proteins

作者: David A Feere

DOI:

关键词: EnzymeMedicineDrug metabolismInternal medicinePharmacologyDrug transportKidney diseaseCytochrome P450ErythropoietinEndocrinologyEnd stage renal disease

摘要:

参考文章(164)
Rommel G. Tirona, Molecular Mechanisms of Drug Transporter Regulation Handbook of experimental pharmacology. ,vol. 201, pp. 373- 402 ,(2011) , 10.1007/978-3-642-14541-4_10
Tim D. Hewitson, Takahiko Ono, Gavin J. Becker, Small animal models of kidney disease: a review. Methods of Molecular Biology. ,vol. 466, pp. 41- 57 ,(2009) , 10.1007/978-1-59745-352-3_4
Jie Cheng, Xiaochao Ma, Frank J Gonzalez, Pregnane X receptor‐ and CYP3A4‐humanized mouse models and their applications British Journal of Pharmacology. ,vol. 163, pp. 461- 468 ,(2011) , 10.1111/J.1476-5381.2010.01129.X
Erik Lipšic, Regien G. Schoemaker, Peter van der Meer, Adriaan A. Voors, Dirk J. van Veldhuisen, Wiek H. van Gilst, Protective Effects of Erythropoietin in Cardiac Ischemia Journal of the American College of Cardiology. ,vol. 48, pp. 2161- 2167 ,(2006) , 10.1016/J.JACC.2006.08.031
Ramiro Jover, Francine Hoffmann, Valeria Scheffler-Koch, Raija L. P. Lindberg, Limited heme synthesis in porphobilinogen deaminase-deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital. FEBS Journal. ,vol. 267, pp. 7128- 7137 ,(2000) , 10.1046/J.1432-1327.2000.01815.X
F. Gouilleux, C. Pallard, I. Dusanter-Fourt, H. Wakao, L.A. Haldosen, G. Norstedt, D. Levy, B. Groner, Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity The EMBO Journal. ,vol. 14, pp. 2005- 2013 ,(1995) , 10.1002/J.1460-2075.1995.TB07192.X
Masayuki Tsujimoto, Daisuke Hatozaki, Daisuke Shima, Hitoshi Yokota, Taku Furukubo, Satoshi Izumi, Tomoyuki Yamakawa, Tetsuya Minegaki, Kohshi Nishiguchi, Influence of Serum in Hemodialysis Patients on the Expression of Intestinal and Hepatic Transporters for the Excretion of Pravastatin Therapeutic Apheresis and Dialysis. ,vol. 16, pp. 580- 587 ,(2012) , 10.1111/J.1744-9987.2012.01100.X